131 related articles for article (PubMed ID: 34107357)
41. Effect of an Active vs Expectant Management Strategy on Successful Resolution of Pregnancy Among Patients With a Persisting Pregnancy of Unknown Location: The ACT or NOT Randomized Clinical Trial.
Barnhart KT; Hansen KR; Stephenson MD; Usadi R; Steiner AZ; Cedars MI; Jungheim ES; Hoeger KM; Krawetz SA; Mills B; Alston M; Coutifaris C; Senapati S; Sonalkar S; Diamond MP; Wild RA; Rosen M; Sammel MD; Santoro N; Eisenberg E; Huang H; Zhang H;
JAMA; 2021 Aug; 326(5):390-400. PubMed ID: 34342619
[TBL] [Abstract][Full Text] [Related]
42. Outcomes of conception subsequent to methotrexate treatment for an unruptured ectopic pregnancy.
Svirsky R; Ben-Ami I; Berkovitch M; Halperin R; Rozovski U
Int J Gynaecol Obstet; 2017 Nov; 139(2):170-173. PubMed ID: 28710772
[TBL] [Abstract][Full Text] [Related]
43. Change in serum beta-human chorionic gonadotropin after abortion with methotrexate and misoprostol.
Creinin MD
Am J Obstet Gynecol; 1996 Feb; 174(2):776-8. PubMed ID: 8623820
[TBL] [Abstract][Full Text] [Related]
44. Presence of a yolk sac on transvaginal sonography is the most reliable predictor of single-dose methotrexate treatment failure in ectopic pregnancy.
Bixby S; Tello R; Kuligowska E
J Ultrasound Med; 2005 May; 24(5):591-8. PubMed ID: 15840789
[TBL] [Abstract][Full Text] [Related]
45. A 5-year experience of the changing management of ectopic pregnancy.
Berry J; Davey M; Hon MS; Behrens R
J Obstet Gynaecol; 2016 Jul; 36(5):631-4. PubMed ID: 27012598
[TBL] [Abstract][Full Text] [Related]
46. Predictors of treatment failure for ectopic pregnancy treated with single-dose methotrexate.
Tawfiq A; Agameya AF; Claman P
Fertil Steril; 2000 Nov; 74(5):877-80. PubMed ID: 11056225
[TBL] [Abstract][Full Text] [Related]
47. A validation of the most commonly used protocol to predict the success of single-dose methotrexate in the treatment of ectopic pregnancy.
Kirk E; Condous G; Van Calster B; Haider Z; Van Huffel S; Timmerman D; Bourne T
Hum Reprod; 2007 Mar; 22(3):858-63. PubMed ID: 17088266
[TBL] [Abstract][Full Text] [Related]
48. Second-dose methotrexate in ectopic pregnancies: the role of beta human chorionic gonadotropin.
Cohen A; Bibi G; Almog B; Tsafrir Z; Levin I
Fertil Steril; 2014 Dec; 102(6):1646-9. PubMed ID: 25241368
[TBL] [Abstract][Full Text] [Related]
49. Pre- and post-treatment patterns of human chorionic gonadotropin for early detection of persistence after a single dose of methotrexate for ectopic pregnancy.
Natale A; Candiani M; Barbieri M; Calia C; Odorizzi MP; Busacca M
Eur J Obstet Gynecol Reprod Biol; 2004 Nov; 117(1):87-92. PubMed ID: 15474251
[TBL] [Abstract][Full Text] [Related]
50. Local management with methotrexate of cesarean scar ectopic pregnancy with live embryo guided by transvaginal ultrasound: A case report.
Leite Jde F; Fraietta R; Elito Júnior J
Rev Assoc Med Bras (1992); 2016 Apr; 62(2):184-5. PubMed ID: 27167550
[TBL] [Abstract][Full Text] [Related]
51. Medical treatment of ectopic pregnancy: a ten-year review of 106 cases at Maharaj Nakorn Chiang Mai Hospital.
Srivichai K; Uttavichai C; Tongsong T
J Med Assoc Thai; 2006 Oct; 89(10):1567-71. PubMed ID: 17128828
[TBL] [Abstract][Full Text] [Related]
52. Methotrexate-treated ectopic pregnancy: beta human chorionic gonadotropin serum changes as a success predictor using a mathematical model validation.
Kovaleva A; Irishina N; Pereira A; Cuesta-Guardiola T; Ortiz-Quintana L
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():35-38. PubMed ID: 27936449
[TBL] [Abstract][Full Text] [Related]
53. The role of day 0 and day 4 β-human chorionic gonadotropin values and initial ultrasound findings in predicting the success of methotrexate treatment in ectopic pregnancy.
Tasgoz FN; Temur M; Dundar B; Kartal E; Ustunyurt E
Ginekol Pol; 2020; 91(7):389-393. PubMed ID: 32779159
[TBL] [Abstract][Full Text] [Related]
54. Yolk sac on transvaginal ultrasound as a prognostic indicator in the treatment of ectopic pregnancy with single-dose methotrexate.
Lipscomb GH; Gomez IG; Givens VM; Meyer NL; Bran DF
Am J Obstet Gynecol; 2009 Mar; 200(3):338.e1-4. PubMed ID: 19254596
[TBL] [Abstract][Full Text] [Related]
55. Single-dose methotrexate for the treatment of ectopic pregnancy: Northwestern Memorial Hospital three-year experience.
Stika CS; Anderson L; Frederiksen MC
Am J Obstet Gynecol; 1996 Jun; 174(6):1840-6; discussion 1846-8. PubMed ID: 8678149
[TBL] [Abstract][Full Text] [Related]
56. Morbid obesity and outcome of ectopic pregnancy following capped single-dose regimen methotrexate.
Hoyos LR; Malik M; Najjar M; Rodriguez-Kovacs J; Abdallah M; Vilchez G; Awonuga AO
Arch Gynecol Obstet; 2017 Feb; 295(2):375-381. PubMed ID: 27844211
[TBL] [Abstract][Full Text] [Related]
57. Medical vs. Surgical treatment of ectopic pregnancy. The University of New Mexico's six-year experience.
Lewis-Bliehall C; Rogers RG; Kammerer-Doak DN; Conway SC; Amaya C; Byrn F
J Reprod Med; 2001 Nov; 46(11):983-8. PubMed ID: 11762155
[TBL] [Abstract][Full Text] [Related]
58. Ectopic pregnancy: using the hCG ratio to select women for expectant or medical management.
Kirk E; Van Calster B; Condous G; Papageorghiou AT; Gevaert O; Van Huffel S; De Moor B; Timmerman D; Bourne T
Acta Obstet Gynecol Scand; 2011 Mar; 90(3):264-72. PubMed ID: 21306315
[TBL] [Abstract][Full Text] [Related]
59. Predictive factors of failure in management of ectopic pregnancy with single-dose methotrexate: a general population-based analysis from the Auvergne Register, France.
Rabischong B; Tran X; Sleiman AA; Larraín D; Jaffeux P; Aublet-Cuvelier B; Pouly JL; Fernandez H
Fertil Steril; 2011 Jan; 95(1):401-4, 404.e1. PubMed ID: 20850718
[TBL] [Abstract][Full Text] [Related]
60. A medical management of interstitial ectopic pregnancy: a 5-year clinical study.
Tang A; Baartz D; Khoo SK
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):107-11. PubMed ID: 16638031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
